Richard Hatchett: Ledger

Stories naming Richard Hatchett. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Role	Organisation	Sources
CEO	CEPI	Brandon BioCatalyst portfolio, Brandon Capital portfolio

Grant ≤$6.4m

Coming in from the cold: needle-free patch technology for mRNA vaccines aims to end need for frozen storage and improve access

Vaxxas partners with CEPI, which will fund preclinical testing of its needle-free vaccine patch for mRNA vaccines, work that could remove cold-storage needs and widen global access to such vaccines.

Brandon Capital portfolio 19 Jan 2023 Vaxxas Biomedical Advanced Research and Development Authority Brandon Capital Healthcare Ventures OneVentures The University of Queensland UniQuest Australian Government CEPI Dr David L Hoey Jane Halton Richard Hatchett UniQuest

Also Brandon BioCatalyst portfolio·@AuManufacturing·@AuManufacturing

Richard Hatchett

Roles

Coverage

Coming in from the cold: needle-free patch technology for mRNA vaccines aims to end need for frozen storage and improve access